Metabologenomics, Inc.

A leading startup company with a mission to create a disease-free world based on “designing intestinal environment”

WINNER OF THE 1st BIOTECH GRAND PRIX IN 2015 IN JAPAN


Metabologenomics, Inc. also known as Metagen is a joint startup company between Keio University and Tokyo Institute of Technology, with a vision to create a disease-free world based on “designing intestinal environment”. Metagen believes that proper control of the intestinal environment helps us stay healthy and prevent disease. Metagen is developing a “intestinal design” technology that controls the intestinal environment by analyzing it through Metagen’s proprietary technology “Metabologenomics®,” an integrated analysis of the genetic information of gut microbiota and intestinal metabolite profiles.

Metagen is the Grand Winner of the 1st BIOTECH GRAND PRIX in 2015 in Japan. COO, Dr. Mizuguchi is from Tokyo Institute of Technology and CEO, Dr. Fukuda is from Keio University. They shared vision and collaborated to apply TECH PLANTER as a researchers team. Soon after the win, they established a company to bring change to the world.

 

Corporate Overview

Company name : Metabologenomics, Inc.

Establishment : 18th March, 2015

Board of directors :

  • CEO, Dr. Shinji Fukuda
  • CTO, Dr. Takuji Yamada
  • CMO, Dr. Dai Ishikawa
  • CFO, Ms. Naoko Matsubara
  • COO, Dr. Yoshinori Mizuguchi

References

Here are 6 Japanese startups with global ambitions (A featured article in Tech in Asia)

Meet Metabologenomics company Metagen Inc., Winner of 1st Bio Science Grand Prix, 2015  (A featured article in GARAGE magazine)

Corporate research overview (PDF)


MEET METAGEN in SOUTH EAST ASIA!

Click the banner for the news release!

News release is coming soon!